beta alethine

DRUG3 trials

Sponsors

LifeTime Pharmaceuticals

Conditions

LymphomaMultiple Myeloma and Plasma Cell NeoplasmPrecancerous Condition

Phase 1

Beta Alethine in Treating Patients With Waldenstrom's Macroglobulinemia

LifeTime PharmaceuticalsLymphoma

Start: 2002-03-31Updated: 2013-12-18

Beta Alethine in Treating Patients With Low-Grade Lymphoma

LifeTime PharmaceuticalsLymphoma

Start: 2000-08-31Updated: 2013-12-18

Beta Alethine in Treating Patients With Myeloma

LifeTime PharmaceuticalsMultiple Myeloma and Plasma Cell Neoplasm, Precancerous Condition

Start: 2000-08-31Updated: 2013-12-18

Related Papers

Abstract 1720: Ax-101, an immunostimulatory small molecule, markedly enhances the antitumor activity of PD1 immune checkpoint blockade in multiple preclinical solid tumor models

Cancer Research2021-07-01